Natdac 60 Tablet

Product Description

1.Technical Specifications

Medicine Type	Allopathic
Dose/Strength	60 mg
Packaging Size	28 Tablet
Packaging Type	Box
Manufactured By	Natco
Brand	Natdac

2. Product Description

Natdac Tablet contains Daclatasvir, a direct-acting antiviral agent targeting the HCV NS5A protein to inhibit viral replication. It is prescribed in combination with Sofosbuvir (with or without Ribavirin) for treatment of chronic hepatitis C infection, especially genotypes 1 and 3.

We are offering Daclatasvir Dihydrochloride Tablet that is utilized in combination with other medications to treat hepatitis C (HCV). The offered range is processed under the supervision of our experts. For strictly adhering to the international quality standards, this tablet is stringently tested by our quality inspectors upon different parameters. Daclatasvir Dihydrochloride Tablet can be used in combination include sofosbuvir, ribavirin, and interferon. The offered tablet is available at pocket friendly prices.

3. Therapeutic Uses

• Treatment of chronic hepatitis C virus (HCV) infection

• Used in combination with sofosbuvir ( ribavirin); NOT as monotherapy

Broad Hepatitis C Coverage

Natdac 60 Tablet targets multiple genotypes (1, 2, 3, and 4) of the Hepatitis C virus, making it versatile for managing chronic infections in adults. Its direct-acting antiviral mechanism works effectively in combination with sofosbuvir, contributing to improved treatment outcomes for patients diagnosed with Hepatitis C.


Safe and Reliable Treatment

This medicine is available only by prescription and requires careful monitoring by your healthcare provider. It is film-coated for ease of swallowing and designed to deliver a consistent dose of Daclatasvirvital for optimum antiviral activity. The tablets shelf life is 24 months, ensuring its efficacy when stored correctly.